SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000332
Filing Date
2020-11-18
Accepted
2020-11-18 12:40:08
Documents
5
Period of Report
2020-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnbt111820form8k.htm 8-K 145009
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 97346
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 17384
4 GRAPHIC image_001.jpg GRAPHIC 84891
5 GRAPHIC image_001.gif GRAPHIC 1667
  Complete submission text file 0001607062-20-000332.txt   380302
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 201323705
SIC: 2834 Pharmaceutical Preparations